Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling
Abstract Background Diverse signalling pathways are involved in carcinogenesis and one of such pathways implicated in many cancers is the interleukin 6/signal transducer and activator of transcription 3 (IL-6/STAT3) signalling pathway. Therefore, inhibition of this pathway is targeted as an anti-can...
Saved in:
Main Authors: | Seth A. Domfeh (Author), Patrick W. Narkwa (Author), Osbourne Quaye (Author), Kwadwo A. Kusi (Author), Gordon A. Awandare (Author), Charles Ansah (Author), Alimatu Salam (Author), Mohamed Mutocheluh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling
by: Jude Tetteh Quarshie, et al.
Published: (2023) -
Evidence of chikungunya virus infections among febrile patients at three secondary health facilities in the Ashanti and the Bono Regions of Ghana.
by: Jonathan Akwasi Adusei, et al.
Published: (2021) -
Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats
by: Arnold Donkor Forkuo, et al.
Published: (2017) -
Chronic administration of cryptolepine nanoparticle formulation alleviates seizures in a neurocysticercosis model
by: Priscilla Kolibea Mante, et al.
Published: (2021) -
Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
by: Xue Hu, et al.
Published: (2021)